Trial intelligence / Profile preview

Neurocognitive testing of methylphenidate effects in children with ADHD

NL-OMON32584Active, not recruiting

Sponsor
Centre for Human Drug Research
Start
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Stroop color-word task, Adaptive tracking and 10 more. Started Oct 2008; status: active, not recruiting.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NL-OMON32584.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON32584.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call